Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 17 March 2025

Table of Content


Buy or sell stocks: Following weak global market sentiments after the US stock market crash, the Indian stock market ended lower on Thursday. The Nifty 50 index finished 73 points lower at 22,397, the BSE Sensex ended 200 points lower at 73,828, while the Bank Nifty index ended marginally higher at 48,060. Auto and IT sector stocks declined, dragging down the markets. Reliance Industries Ltd. contributed most to the index decline, decreasing 0.7%, while Shriram Finance Ltd. experienced the most significant drop, falling 2.7%. 

Nifty Realty, Media, and Financial Services lost the most among sectoral indices, while the Bank Nifty and PSU Bank indices closed in positive territory. Cash market volumes on the NSE decreased by 15% compared to the previous day. The Nifty Midcap and Smallcap 100 indices underperformed relative to Nifty, with additional losses of 0.75% and 0.98%, respectively. For the fourth consecutive day, declining shares outnumbered advancing ones, resulting in a BSE advance-decline ratio 0.62.

Stock market next week

Sumeet Bagadia, Executive Director at Choice Broking, believes the Indian stock market is cautious as the Nifty 50 index is close to its crucial support at 22,300 to 22,250. The Choice Broking expert said the 50-stock index is a broader 22,000 to 22,650 range. A bullish or bearish trend can be assumed on the breakage of either side of this range. He advised investors to look at technically strong stocks and suggested buying these three buy-or-sell stocks for Monday: Kotak Mahindra Bank, REC, and Sun Pharmaceuticals.

Buy or sell stocks

1] Kotak Mahindra Bank: Buy at 1985.10, target 2125, stop loss 1920.

Kotak Mahindra Bank’s share price currently trades at 1985.10, maintaining a strong upward trajectory. The stock has consistently formed higher and lower highs, reinforcing its bullish momentum. Notably, it recently reached a fresh 52-week high of 1997.70. Trading well above its 20-day EMA, 50-day EMA, and 200-day EMA, Kotak Mahindra Bank’s share price demonstrates robust support across both short-term and long-term trends. This technical strength and a breakout above a key resistance level underscores the stock’s potential for further appreciation. If the upward momentum persists and the stock breaches higher levels, it could target 2125 soon.

On the downside, immediate support for Kotak Mahindra Bank’s share price is 1950. The Relative Strength Index (RSI) is currently at 60.88. and trending upward, reflecting growing buying momentum. To manage risk effectively, a stop-loss at 1920 is suggested to guard against any unexpected market reversals.

In conclusion, based on the technical analysis and current market conditions, Kotak Mahindra Bank’s share price presents a promising buying opportunity for those aiming for a 2125 target, provided that appropriate risk management strategies are in place.

2] REC: Buy at 52.65, target 56, stop loss 51.

The REC’s share price is currently trading at 52.65 and is taking support at the 200 EMA, indicating potential strength. A decisive close above 53.50 could trigger further upside, with short-term targets of 55 and 56.

On the downside, 52 is an immediate support level, making it a potential buy-on-dip opportunity. To manage risk, a stop-loss at 51 is recommended.

The RSI at 36.64 is trending upward, signalling a possible momentum shift. The stock is also forming an inside candle breakout, and a move above 54, in conjunction with the 100 EMA, would confirm a bullish breakout. However, a breakdown below 52 could lead to further downside pressure.

3] Sun Pharma: Buy at 1683.45, target 1800, stop loss 1610.

Sun Pharma share is trading at 1683.45, exhibiting signs of recovery following a prolonged downtrend. The stock has formed a potential bottoming pattern, indicating the possibility of a trend reversal. Recent price action, supported by increasing volume, suggests renewed buying interest. Additionally, the stock has crossed above its 20-day exponential moving average (EMA), signalling a short-term shift in momentum. However, it remains below the 50-day and 200-day EMAs, indicating that a complete trend reversal is yet to be confirmed. If the stock successfully breaks above this level, it could reach a short-term target of 1800.

On the upside, resistance is observed in the 1700 to 1750 range, while key support is located between 1660 to 1640. The relative strength index (RSI) currently stands at 53.20, reflecting improving momentum and gradually moving toward bullish territory. To effectively manage risk, a stop-loss at 1610 is recommended to protect against potential market reversals.

In conclusion, based on the technical analysis and current market conditions, Sun Pharma share presents a promising buying opportunity for those aiming for a 1800 target, provided that appropriate risk management strategies are in place.

Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business NewsMarketsStock MarketsBuy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 17 March 2025

MoreLess



Source link

AIMPWA

mmkrishnandasu@gmail.com http://msmenews.sbs

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News

Trending News

Editor's Picks

IPO News Today Live Updates on March 15, 2025 : Klarna IPO: Swedish fintech files for blockbuster IPO, targets $15 billion valuation after 24% revenue surge: 5 Points

IPO News Today Live Updates: Navigate the dynamic world of initial public offerings with our dedicated IPO News section. Here, we bring you the latest updates on companies stepping into the public market, offering insights into their financial strategies, valuation, and market reception. Whether you’re an investor looking for new opportunities or simply curious about...

ALL INDIA MSMES PROMOTION AND WELFARE ASSOCIATION

Quick Links

Popular Categories

Must Read

AIMPWA © 2025- All Right Reserved. Designed and Developed by  growGX.com